Contracts › 75N93022F00002
75N93022F00002: Comprehensive in Vitro Antiviral Screening Against Viruses of Pandemic Potential Under Antiviral Program for Pandemics (APP)
Awarded to Utah State University by National Institutes of Health (NIH).
$2.0Mobligated
$2.3Mpotential value
31 December 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93022F00002 |
|---|---|
| Vehicle | 75N93019D00021 |
| Awardee | Utah State University |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | ID |
| Offers received | 2 |
| Period of performance | 14 June 2022 to 31 December 2026 |
| Potential end | 31 December 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record